The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis
Open accessAbstract
AbstractBackground and Aims The prevalence of nonalcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH) is increasing at an alarming rate. The role of bile acids in the development and progression of NAFLD to NASH and cirrhosis is poorly understood. This study aimed to quantify the bile acid metabolome in healthy subjects and patients with non-cirrhotic NASH under fasting conditions and after a standardized meal.MethodsLiquid chromatography tandem mass spectroscopy was used to quantify 30 serum and 16 urinary bile acids from 15 healthy volunteers and 7 patients with biopsy-confirmed NASH. Bile acid concentrations were measured at two fasting and four post-prandial time points following a high-fat meal to induce gallbladder contraction and bile acid reabsorption from the intestine.ResultsPatients with NASH had significantly higher total serum bile acid concentrations than healthy subjects under fasting conditions (2.2- to 2.4-fold increase in NASH; NASH 2595–3549 µM and healthy 1171–1458 µM) and at all post-prandial time points (1.7- to 2.2-fold increase in NASH; NASH 4444–5898 µM and healthy 2634–2829 µM). These changes were driven by increased taurine- and glycine-conjugated primary and secondary bile acids. Patients with NASH exhibited greater variability in their fasting and post-prandial bile acid profile.ConclusionsResults indicate that patients with NASH have higher fasting and post-prandial exposure to bile acids, including the more hydrophobic and cytotoxic secondary species. Increased bile acid exposure may be involved in liver injury and the pathogenesis of NAFLD and NASH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791 · cited 1×
“Patients with NASH were recruited from the University of North Carolina at Chapel Hill (UNC-CH) hepatology clinic and were eligible for enrollment based on the following: biopsy-confirmed non-cirrhotic NASH with nonalcoholic fatty liver disease activity score (NAS) [3 [19]; BMI B 45 kg/m(2).”
MethodPrevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220 · cited 1×
“Bile acids are ligands for FXR, TGR5, and PXR, which are involved in diverse functions including prevention of intestinal bacterial overgrowth [28], stimulating the release of glucagon-like peptide-1 [29], and regulating adipose and muscle tissue energy expenditure [30].”
BackgroundThe Enzymes, Regulation, and Genetics of Bile Acid Synthesis
Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069 · cited 1×
“Bile acid coenzyme A:amino acid N-acyltransferase enzyme (BAAT) is the primary enzyme responsible for conjugation of bile acids with taurine and glycine [26].”
BackgroundTGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
Thomas, C., Gioiello, A., Noriega, L., Strehle, A., Oury, J., Rizzo, G., Macchiarulo, A., Yamamoto, H., Mataki, C., Pruzanski, M., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.08.001 · Cited by 1,885
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.001 · Cited by 1,775
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
Inagaki, T., Moschetta, A., Lee, Y.-K., Peng, L., Zhao, G., Downes, M., Yu, R. T., Shelton, J. M., Richardson, J. A., Repa, J. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509592103 · Cited by 1,164 · cited 1×
“Bile acids are ligands for FXR, TGR5, and PXR, which are involved in diverse functions including prevention of intestinal bacterial overgrowth [28], stimulating the release of glucagon-like peptide-1 [29], and regulating adipose and muscle tissue energy expenditure [30].”
BackgroundInteractions Between the Intestinal Microbiome and Liver Diseases
Schnabl, B., & Brenner, D. A. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.020 · Cited by 971 · cited 3×
“Modification of hepatic bile acid metabolism and transporters [13–15] and/or the gut microbiome [6, 16] in NAFLD may alter the predominant bile acid species, thereby impacting post-prandial bile acid-dependent signaling and modulating hepatic inflammatory cascades.”
BackgroundMudaliar, S., Henry, R. R., Sanyal, A. J., Morrow, L., Marschall, H., Kipnes, M., Adorini, L., Sciacca, C. I., Clopton, P., Castelloe, E., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.042 · Cited by 931 · cited 1×
“Due to these signaling properties and target selectivity achievable with minor physicochemical modification, bile acids and their close derivatives have become promising drug candidates for treating metabolic and hepatic diseases [11, 12].”
BackgroundHepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
Baffy, G., Brunt, E. M., & Caldwell, S. H. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.027 · Cited by 858
Intestinal microbiota in patients with nonalcoholic fatty liver disease
Mouzaki, M., Comelli, E. M., Arendt, B. M., Bonengel, J., Fung, S. K., Fischer, S. E., McGilvray, I. D., & Allard, J. P. (2013) · Hepatology · doi:10.1002/hep.26319 · Cited by 749 · cited 2×
“Modification of hepatic bile acid metabolism and transporters [13–15] and/or the gut microbiome [6, 16] in NAFLD may alter the predominant bile acid species, thereby impacting post-prandial bile acid-dependent signaling and modulating hepatic inflammatory cascades.”
BackgroundBile-acid-induced cell injury and protection
Perez, M. J., & Briz, O. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1677 · Cited by 717
Bile acids as carcinogens in human gastrointestinal cancers
Bernstein, H., Bernstein, C., Payne, C. M., Dvorakova, K., & Garewal, H. (2005) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2004.08.001 · Cited by 611
Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas
Faubion, W. A., Guicciardi, M. E., Miyoshi, H., Bronk, S. F., Roberts, P. J., Svingen, P. A., Kaufmann, S. H., & Gores, G. J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4765 · Cited by 536
Plasma Metabolomic Profile in Nonalcoholic Fatty Liver Disease
Kalhan, S. C., Guo, L., Edmison, J., Dasarathy, S., McCullough, A. J., Hanson, R. W., & Milburn, M. (2011) · Metabolism · doi:10.1016/j.metabol.2010.03.006 · Cited by 532
Rodrigues, C. M., Fan, G., Ma, X., Kren, B. T., & Steer, C. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1325 · Cited by 520
Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies
Larsson, S. C., & Wolk, A. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603932 · Cited by 495
Bile Acids: The Good, the Bad, and the Ugly
Hofmann, A. F. (1999) · Physiology · doi:10.1152/physiologyonline.1999.14.1.24 · Cited by 378
Rodrigues, C. M. P., Fan, G., Wong, P. Y., Kren, B. T., & Steer, C. J. (1998) · Molecular Medicine · doi:10.1007/bf03401914 · Cited by 334
García-Cañaveras, J. C., Donato, M. T., Castell, J. V., & Lahoz, A. (2012) · Journal of Lipid Research · doi:10.1194/jlr.d028803 · Cited by 276
Promoting Effect of Sodium Deoxycholate on Colon Adenocarcinomas in Germfree Rats2
Reddy, B. S., Narasawa, T., Weisburger, J. H., & Wynder, E. L. (1976) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/56.2.441 · Cited by 264
Spivey, J. R., Bronk, S. F., & Gores, G. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116546 · Cited by 256
Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis
Tanaka, N., Matsubara, T., Krausz, K. W., Patterson, A. D., & Gonzalez, F. J. (2012) · Hepatology · doi:10.1002/hep.25630 · Cited by 249
Role of nuclear receptor SHP in metabolism and cancer
Zhang, Y., Hagedorn, C. H., & Wang, L. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.10.006 · Cited by 235
Bechmann, L. P., Kocabayoglu, P., Sowa, J.-P., Sydor, S., Best, J., Schlattjan, M., Beilfuss, A., Schmitt, J., Hannivoort, R. A., Kilicarslan, A., et al. (2013) · Hepatology · doi:10.1002/hep.26225 · Cited by 233
Bile acid levels are increased in the liver of patients with steatohepatitis
Aranha, M. M., Cortez-Pinto, H., Costa, A., da Silva, I. B. M., Camilo, M. E., de Moura, M. C., & Rodrigues, C. M. P. (2008) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3282f4710a · Cited by 211
Obesity and the risk of gallbladder cancer: a meta-analysis
Larsson, S. C., & Wolk, A. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603703 · Cited by 190
Lake, A. D., Novak, P., Shipkova, P., Aranibar, N., Robertson, D., Reily, M. D., Lu, Z., Lehman-McKeeman, L. D., & Cherrington, N. J. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.01.022 · Cited by 189
Colonic inflammation and secondary bile acids in alcoholic cirrhosis
Kakiyama, G., Hylemon, P. B., Zhou, H., Pandak, W. M., Heuman, D. M., Kang, D. J., Takei, H., Nittono, H., Ridlon, J. M., Fuchs, M., et al. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00315.2013 · Cited by 179
FXR and PXR: Potential therapeutic targets in cholestasis
Jonker, J. W., Liddle, C., & Downes, M. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.06.012 · Cited by 167
Profiling of Serum Bile Acids in a Healthy Chinese Population Using UPLC–MS/MS
Xie, G., Wang, Y., Wang, X., Zhao, A., Chen, T., Ni, Y., Wong, L., Zhang, H., Zhang, J., Liu, C., et al. (2015) · Journal of Proteome Research · doi:10.1021/pr500920q · Cited by 160
Self-citationTrottier, J., Bialek, A. P., Caron, P., Straka, R. J., Heathcote, J., Milkiewicz, P., & Barbier, O. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2011.10.025 · Cited by 158
Hardwick, R. N., Fisher, C. D., Canet, M. J., Scheffer, G. L., & Cherrington, N. J. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.041012 · Cited by 148
(2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.001 · Cited by 144
Bringmann, G., G�ssregen, S., Vitt, D., & Stowasser, R. (1998) · Journal of Molecular Modeling · doi:10.1007/s0089480040165 · Cited by 113
Trottier, J., Bialek, A. P., Caron, P., Straka, R. J., Milkiewicz, P., & Barbier, O. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022094 · Cited by 108
Altered morphine glucuronide and bile acid disposition in patients with nonalcoholic steatohepatitis
Ferslew, B. C., Johnston, C., Tsakalozou, E., Bridges, A. S., Paine, M., Jia, W. P., Stewart, P., Barritt, A. S., & Brouwer, K. L. R. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.66 · Cited by 90
Self-citationGallbladder Emptying Stimuli in Obese and Normal–Weight Subjects
Stone, B. G., Ansel, H. J., Peterson, F. J., & Gebhard, R. L. (1992) · Hepatology · doi:10.1002/hep.1840150508 · Cited by 79
Alcoholic and non-alcoholic steatohepatitis
Neuman, M. G., French, S. W., French, B. A., Seitz, H. K., Cohen, L. B., Mueller, S., Osna, N. A., Kharbanda, K. K., Seth, D., Bautista, A. P., et al. (2014) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2014.09.005 · Cited by 77
The relationship between postprandial bile acid concentration, GLP‐1, PYY and ghrelin
Roberts, R. E., Glicksman, C., Alaghband-Zadeh, J., Sherwood, R. A., Akuji, N., & le Roux, C. W. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03886.x · Cited by 75
Jia, X., Naito, H., Yetti, H., Tamada, H., Kitamori, K., Hayashi, Y., Wang, D., Yanagiba, Y., Wang, J., Ikeda, K., et al. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2747-1 · Cited by 40
Cited by
The gut-liver axis in liver disease: Pathophysiological basis for therapy
Albillos, A., de Gottardi, A., & Rescigno, M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.003 · Cited by 2,166
The gut-liver axis and the intersection with the microbiome
Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0011-z · Cited by 1,480
Chávez-Talavera, O., Tailleux, A., Lefebvre, P., & Staels, B. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.055 · Cited by 970
Jiao, N., Baker, S. S., Chapa-Rodriguez, A., Liu, W., Nugent, C. A., Tsompana, M., Mastrandrea, L., Buck, M. J., Baker, R. D., Genco, R. J., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314307 · Cited by 737
The gut–liver axis and gut microbiota in health and liver disease
Hsu, C. L., & Schnabl, B. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00904-3 · Cited by 737
Metadata
- Authors
- Ferslew, B. C., Xie, G., Johnston, C. K., Su, M., Stewart, P. W., Jia, W., Brouwer, K. L. R., & Sidney Barritt, A.
- Venue
- Digestive Diseases and Sciences
- Published
- 2015-07-03
- Volume
- 60
- Issue
- 11
- Pages
- 3318-3328
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- OpenAlex
- W774501851
- Cited by
- 335
- References
- 42
- FWCI
- 16.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.